Skip to main content
SleepCited

5-HTP cho Mất Ngủ

B Bằng chứng Ít nhất một thử nghiệm ngẫu nhiên ủng hộ điều này, với các kết quả phần lớn nhất quán.

Dựa trên 42 nghiên cứu (1 RCT) với 84 người tham gia. 35/42 nghiên cứu cho thấy tác động tích cực.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003D5\u002Dhtp\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Kết luận

5-HTP may support better sleep through its role in serotonin and melatonin production, but human evidence remains limited despite strong preclinical results.

  • 35 out of 42 studies show positive effects on sleep, but most are animal or lab studies
  • 5-HTP is a natural precursor to serotonin and melatonin, key neurotransmitters for sleep regulation
  • Only 1 randomized controlled trial (RCT) in humans has been conducted
  • A GABA/5-HTP combination has shown sleep-promoting effects in preclinical models

Key Study Findings

animal study / preclinical
Guhan Yangsheng Jing alleviates sleep deprivation-induced neuronal injury via neurotransmitter rebalancing, mitochondrial protection, and inhibition …
Dose: Guhan Yangsheng Jing (GHYSJ) multi-herbal decoction (dose not specified in abstract) so với: Placebo Hiệu quả: None None
Other
Sleep deprivation activated AMPK/FOXO3a signaling mediates pineal autophagy impairment to reduce melatonin secretion in CUMS …
Dose: None so với: CUMS+SD model without intervention Outcome: Depression/insomnia behaviors and melatonin secretion Hiệu quả: None None

Đối tượng nghiên cứu: CUMS + sleep deprivation rat model

preclinical animal/in vitro study
Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice …
Dose: 60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL so với: Placebo Hiệu quả: None None
Animal Study
Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats.
Dose: Cinnamic acid (CA) administered to rats (dose not specified) so với: Placebo Hiệu quả: None None
animal study / preclinical
[Effect of Fushen Decoction on 5-HT system and GABA expression in mouse model of PCPA-induced …
Dose: Fushen Decoction 10, 20, and 40 g/kg; coffee 1 g/kg (PCPA-induced insomnia model) so với: Placebo Hiệu quả: None None

Key Statistics

43

Nghiên cứu

84

Người tham gia

Positive

B

Xếp hạng

Referenced Papers

Child and adolescent … 2023 5 trích dẫn
Frontiers in bioengineering … 2021 18 trích dẫn
Journal of ethnopharmacology 2008 55 trích dẫn
Primary care 2002 43 trích dẫn
Alternative medicine review … 1998 216 trích dẫn
Alternative medicine review … 1998
Electroencephalography and clinical … 1984 2 trích dẫn

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Liều lượng thường dùng

sleep:
100-300 mg, 30-45 min before bed

Giới hạn trên: Not established; serotonin syndrome risk with SSRIs

Liều lượng đã nghiên cứu

Liều lượng Thời gian Hiệu quả N
Guhan Yangsheng Jing (GHYSJ) multi-herbal decoction (dose not specified in abstract) -- Positive --
None -- Positive --
60 and 100 mg/kg (mice); 100 and 200 µg/mL (HT-22 cells); withanolide A 1.56 and 3.12 µg/mL -- Positive --
Cinnamic acid (CA) administered to rats (dose not specified) -- Positive --
None -- Positive --
Fushen Decoction 10, 20, and 40 g/kg; coffee 1 g/kg (PCPA-induced insomnia model) -- Positive --
5-HTP encapsulated in β-cyclodextrin/corn starch composite nanoparticles (dose not specified) -- Positive --
None -- Positive --

Thời điểm dùng tốt nhất: 30-45 minutes before bed

Safety & Side Effects

Tác dụng phụ đã được báo cáo

  • Nausea
  • Diarrhea
  • Heartburn
  • Stomach pain
  • Drowsiness

Tương tác đã biết

  • SSRIs/SNRIs — serious risk of serotonin syndrome
  • MAOIs — dangerous serotonin accumulation
  • Tramadol — increased serotonin syndrome risk
  • Carbidopa — may cause scleroderma-like skin changes

Mức hấp thụ tối đa cho phép: Not established; serotonin syndrome risk with SSRIs

Luôn tham khảo ý kiến bác sĩ trước khi bắt đầu sử dụng bất kỳ thực phẩm bổ sung nào.Luôn tham khảo ý kiến chuyên gia y tế trước khi sử dụng bất kỳ thực phẩm chức năng nào.

Frequently Asked Questions

Does 5-HTP help with Mất Ngủ?
Based on 43 studies with 84 participants, there is moderate evidence from clinical studies that 5-HTP may support Mất Ngủ management. Our evidence grade is B (Good Evidence).
How much 5-HTP should I take for Mất Ngủ?
Studies have used various dosages. A commonly studied range is 100-300 mg, 30-45 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 5-HTP?
Reported side effects may include Nausea, Diarrhea, Heartburn, Stomach pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 5-HTP and Mất Ngủ?
We rate the evidence as Grade B (Good Evidence). This rating is based on 43 peer-reviewed studies with 84 total participants. The overall direction of effect is positive.

References

  1. [1] Xinying Fu et al.. J Ethnopharmacol. 2026. Guhan Yangsheng Jing alleviates sleep deprivation-induced neuronal injury via neurotransmitter rebalancing, mitochondrial protection, and inhibition of pyroptosis. doi:10.1016/j.jep.2026.121209 PubMed
  2. [2] Hyeongyeong Kim et al.. J Ethnopharmacol. 2025. Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice by enhancing the brain-derived neurotrophic … doi:10.1016/j.jep.2024.119224 PubMed
  3. [3] Jingyi Li et al.. Psychopharmacology (Berl). 2025. Ginsenoside Rg1 alleviates PCPA-induced insomnia by inhibiting NLRP3 inflammasome activation and pyroptosis through the Nrf2/HO-1 pathway in mice. doi:10.1007/s00213-025-06828-5 PubMed
  4. [4] Zirong Li et al.. Neurosci Lett. 2025. Sleep deprivation activated AMPK/FOXO3a signaling mediates pineal autophagy impairment to reduce melatonin secretion in CUMS + SD rats leading to … doi:10.1016/j.neulet.2024.138091 PubMed
  5. [5] Lin Gao et al.. Int J Biol Macromol. 2025. Construction of composite nanoparticles of β-cyclodextrin and corn starch encapsulating 5-hydroxytryptophan for sustained release and sleep improvement in vivo. doi:10.1016/j.ijbiomac.2025.140831 PubMed
  6. [6] Xiaona Ye et al.. Int Immunopharmacol. 2025. Promotion of sleep by cinnamic acid in parachlorophenylalanine-induced insomnia in rats. doi:10.1016/j.intimp.2025.114852 PubMed
  7. [7] Jun-Hang Hu et al.. Zhongguo Zhong Yao Za Zhi. 2025. [Effect of Fushen Decoction on 5-HT system and GABA expression in mouse model of PCPA-induced insomnia]. doi:10.19540/j.cnki.cjcmm.20241101.401 PubMed
  8. [8] Xinying Fu et al.. J Ethnopharmacol. 2024. Guhan Yangsheng Jing mitigates hippocampal neuronal pyroptotic injury and manifies learning and memory capabilities in sleep deprived mice via the … doi:10.1016/j.jep.2024.117972 PubMed
  9. [9] Hsin-Chieh Kung et al.. Int J Mol Sci. 2024. Biosynthetic Pathways of Tryptophan Metabolites in Saccharomyces cerevisiae Strain: Insights and Implications. doi:10.3390/ijms25094747 PubMed
  10. [10] Deepika Singh et al.. Bioorg Chem. 2023. Development and challenges in the discovery of 5-HT1A and 5-HT7 receptor ligands. doi:10.1016/j.bioorg.2022.106254 PubMed
  11. [11] Swapna N Deshpande et al.. Child Adolesc Psychiatr Clin N Am. 2023. Complementary and Integrative Approaches to Sleep Disorders in Children. doi:10.1016/j.chc.2022.08.008 PubMed
  12. [12] Zhen Zhang et al.. Microb Cell Fact. 2022. Metabolic engineering of Escherichia coli for efficient production of L-5-hydroxytryptophan from glucose. doi:10.1186/s12934-022-01920-3 PubMed
  13. [13] Xin-Xin Liu et al.. Front Bioeng Biotechnol. 2021. Advances in the Microbial Synthesis of 5-Hydroxytryptophan. doi:10.3389/fbioe.2021.624503 PubMed
  14. [14] Jingjing Shao et al.. Food Funct. 2020. Ginsenoside Rg5/Rk1 ameliorated sleep via regulating the GABAergic/serotoninergic signaling pathway in a rodent model. doi:10.1039/c9fo02248a PubMed
  15. [15] Da Xu et al.. Appl Microbiol Biotechnol. 2020. Enhanced production of 5-hydroxytryptophan through the regulation of L-tryptophan biosynthetic pathway. doi:10.1007/s00253-020-10371-y PubMed
  16. [16] Rui Shi et al.. Front Pharmacol. 2019. Loganin Exerts Sedative and Hypnotic Effects via Modulation of the Serotonergic System and GABAergic Neurons. doi:10.3389/fphar.2019.00409 PubMed
  17. [17] Oliviero Bruni et al.. Expert Opin Pharmacother. 2019. Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders. doi:10.1080/14656566.2019.1674283 PubMed
  18. [18] Ning Mou et al.. RSC Adv. 2019. Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides. doi:10.1039/c9ra01549c PubMed
  19. [19] Hong-Yan Zhu et al.. RSC Adv. 2018. 4-Hydroxybenzyl alcohol derivatives and their sedative-hypnotic activities. doi:10.1039/c8ra01972j PubMed
  20. [20] Ki-Bae Hong et al.. Nutr Res Pract. 2018. Two combined amino acids promote sleep activity in caffeine-induced sleepless model systems. doi:10.4162/nrp.2018.12.3.208 PubMed
  21. [21] Ki-Bae Hong et al.. Life Sci. 2016. Sleep-promoting effects of a GABA/5-HTP mixture: Behavioral changes and neuromodulation in an invertebrate model. doi:10.1016/j.lfs.2016.02.086 PubMed
  22. [22] Meng-Fei Ye et al.. Biomed Rep. 2015. Flos Albiziae aqueous extract and its active constituent quercetin potentiate the hypnotic effect of pentobarbital via the serotonergic system. doi:10.3892/br.2015.518 PubMed
  23. [23] Yuheng Lin et al.. ACS Synth Biol. 2014. Engineering bacterial phenylalanine 4-hydroxylase for microbial synthesis of human neurotransmitter precursor 5-hydroxytryptophan. doi:10.1021/sb5002505 PubMed
  24. [24] D Dalla Libera et al.. Neurol Sci. 2014. Complementary and alternative medicine (CAM) use in an Italian cohort of pediatric headache patients: the tip of the iceberg. doi:10.1007/s10072-014-1756-y PubMed
  25. [25] Chenning Zhang et al.. Eur J Pharmacol. 2014. Pharmacological evaluation of sedative and hypnotic effects of schizandrin through the modification of pentobarbital-induced sleep behaviors in mice. doi:10.1016/j.ejphar.2014.09.012 PubMed
  26. [26] Chenning Zhang et al.. Fitoterapia. 2014. Gomisin N isolated from Schisandra chinensis augments pentobarbital-induced sleep behaviors through the modification of the serotonergic and GABAergic system. doi:10.1016/j.fitote.2014.04.017 PubMed
  27. [27] Dingyan Chen et al.. J Huazhong Univ Sci Technolog Med Sci. 2012. Neurotransmitter-precursor-supplement intervention for detoxified heroin addicts. doi:10.1007/s11596-012-0073-z PubMed
  28. [28] Sara Baraldi et al.. J Clin Psychopharmacol. 2012. Symptomatic treatment of interferon-α-induced depression in hepatitis C: a systematic review. doi:10.1097/JCP.0b013e31825d9982 PubMed
  29. [29] Benjamin S Weeks. Med Sci Monit. 2009. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. PubMed
  30. [30] George J Trachte et al.. Neuropsychiatr Dis Treat. 2009. Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in … doi:10.2147/ndt.s5040 PubMed
  31. [31] Li-En Wang et al.. Pharmacol Biochem Behav. 2008. Spinosin, a C-glycoside flavonoid from semen Zizhiphi Spinozae, potentiated pentobarbital-induced sleep via the serotonergic system. doi:10.1016/j.pbb.2008.03.022 PubMed
  32. [32] Subrat Kumar Bhattamisra et al.. J Ethnopharmacol. 2008. Antidepressant activity of standardised extract of Marsilea minuta Linn. doi:10.1016/j.jep.2008.01.012 PubMed
  33. [33] Amy Lynn Meolie et al.. J Clin Sleep Med. 2005. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. PubMed
  34. [34] Michele M Larzelere et al.. Prim Care. 2002. Anxiety, depression, and insomnia. doi:10.1016/s0095-4543(01)00003-3 PubMed
  35. [35] Jun Gao et al.. Brain Res. 2002. Modulation of serotonergic projection from dorsal raphe nucleus to basolateral amygdala on sleep-waking cycle of rats. doi:10.1016/s0006-8993(02)02625-2 PubMed
  36. [36] T C Birdsall. Altern Med Rev. 1998. 5-Hydroxytryptophan: a clinically-effective serotonin precursor. PubMed
  37. [37] J H Juhl. Altern Med Rev. 1998. Fibromyalgia and the serotonin pathway. PubMed
  38. [38] M Touret et al.. Exp Brain Res. 1991. The role of 5-hydroxytryptophan (5-HTP) in the regulation of the sleep/wake cycle in parachlorophenylalanine (p-CPA) pretreated rat: a multiple approach … doi:10.1007/BF00231046 PubMed
  39. [39] F Laffont et al.. Electroencephalogr Clin Neurophysiol. 1984. Sleep disturbances in a case of brain-stem lesions; pharmacological study. doi:10.1016/0013-4694(84)90005-1 PubMed
  40. [40] M Sallanon et al.. C R Seances Acad Sci III. 1983. [Implication of hypothalamic structures in indolaminergic mechanisms of paradoxical sleep]. PubMed
  41. [41] M Sallanon et al.. Brain Res. 1982. Restoration of paradoxical sleep by cerebrospinal fluid transfer to PCPA pretreated insomniac cats. doi:10.1016/0006-8993(82)91281-1 PubMed
  42. [42] M Sallanon et al.. Eur J Pharmacol. 1982. 5-HT antagonists suppress sleep and delay its restoration after 5-HTP in p-chlorophenylalanine-pretreated cats. doi:10.1016/0014-2999(82)90549-0 PubMed
  43. [43] R F Laguzzi. Brain Res. 1982. Effects of serotonin synthesis inhibition on sleep in hippocampectomized rats. doi:10.1016/0006-8993(82)90659-x PubMed
  44. [44] F Petitjean et al.. C R Seances Acad Sci D. 1980. [Insomnia induced by P-chlorophenylalanine in cats. Its reversibility by intraventricular injections of indolamines]. PubMed
  45. [45] T Sakurada et al.. Jpn J Pharmacol. 1977. Effects of p-chlorophenylalanine (p-CPA) on sleep in olfactory bulb lesioned rats. doi:10.1254/jjp.27.389 PubMed

Tuyên bố miễn trừ FDA: Các tuyên bố này chưa được Cục Quản lý Thực phẩm và Dược phẩm (FDA) đánh giá. Các sản phẩm và thông tin trên trang web này không nhằm mục đích chẩn đoán, điều trị, chữa bệnh hoặc phòng ngừa bất kỳ bệnh nào. Xếp hạng bằng chứng được trình bày dựa trên phân tích của chúng tôi về nghiên cứu đã bình duyệt được công bố và không cấu thành tư vấn y khoa. Luôn tham khảo ý kiến chuyên gia y tế trước khi bắt đầu bất kỳ chế độ thực phẩm chức năng nào.